Prenatal Care Practice Questions

Q: Which of the following is not an indication for amniocentesis for chromosomal detection?

Gestational diabetes mellitus. **Explanation:** Amniocentesis is an invasive prenatal diagnostic procedure used primarily to obtain fetal cells for karyotyping and genetic analysis. The indications for chromosomal detection are based on an increased risk of aneuploidy or genetic disorders. **Why Gestational Diabetes Mellitus (GDM) is the correct answer:** GDM is a metabolic complication of pregnancy characterized by glucose intolerance. While GDM increases the risk of macrosomia, polyhydramnios, and neonatal hypoglycemia, it is **not** associated with an increased risk of fetal chromosomal anomalies. Therefore, GDM alone is not an indication for amniocentesis. **Analysis of Incorrect Options:** * **Previous Down’s syndrome child:** A history of a prior pregnancy affected by trisomy increases the recurrence risk, making genetic testing essential in subsequent pregnancies. * **Maternal age > 35 years:** Advanced maternal age is a classic indication due to the increased risk of non-disjunction during meiosis, leading to trisomies (e.g., Down syndrome). * **Parents with known chromosomal anomaly:** If either parent is a carrier of a balanced translocation or other structural rearrangements, there is a high risk of unbalanced gametes and fetal chromosomal defects. **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** Amniocentesis is ideally performed between **15–20 weeks** of gestation. * **Complication:** The most significant risk is procedure-related pregnancy loss (approx. 0.5%). * **Other Indications:** Assessment of fetal lung maturity (L/S ratio), diagnosis of fetal infections (CMV), and therapeutic drainage of polyhydramnios. * **Gold Standard:** While screening (Dual/Quadruple markers) provides risk probability, amniocentesis provides a **definitive diagnosis** via karyotyping or FISH.

Q: Which of the following is NOT a finding associated with the prenatal diagnosis for Down syndrome?

Increased umbilical blood flow. **Explanation:** The prenatal diagnosis of Down syndrome (Trisomy 21) relies on a combination of biochemical markers and ultrasound "soft markers." **Why Option C is the correct answer:** In pregnancies affected by Down syndrome, there is typically **increased resistance** in the placental vasculature. This leads to **decreased or abnormal umbilical blood flow** (often visualized as absent or reversed end-diastolic flow in Doppler studies), rather than increased flow. Abnormal Doppler findings in the ductus venosus are also common. **Analysis of incorrect options:** * **Option A (Reduced femur/humerus length):** Shortening of the long bones (especially the humerus) is a classic second-trimester ultrasound marker for Down syndrome, reflecting overall skeletal growth restriction. * **Option B (Nuchal translucency >3mm):** Increased Nuchal Translucency (NT) measured between 11–13 weeks + 6 days is the most sensitive ultrasound screening marker for Trisomy 21. A value >3mm (or >95th percentile) is highly significant. * **Option C (Ventricular septal defect):** Approximately 40-50% of Down syndrome fetuses have congenital heart disease. While **Atrioventricular Septal Defect (AVSD)** is the most characteristic, VSDs and ASDs are also frequently encountered. **NEET-PG High-Yield Pearls:** * **Best Screening Test:** Combined Test (NT + PAPP-A + hCG) in the first trimester. * **Triple Test Findings:** Low AFP, Low Unconjugated Estriol (uE3), and **High hCG**. * **Quadruple Test:** Adds **High Inhibin A** to the triple test (most sensitive biochemical screen). * **Most Common Cardiac Defect:** Endocardial cushion defect (AVSD). * **Other USG markers:** Absent/hypoplastic nasal bone, echogenic intracardiac focus, and "double bubble" sign (duodenal atresia).

Q: Which vaccine is not indicated during pregnancy?

Rubella. ### Explanation The core principle in obstetric immunization is the **avoidance of live-attenuated vaccines**. **1. Why Rubella is the Correct Answer:** Rubella is a **live-attenuated virus vaccine**. The primary concern is the theoretical risk of the vaccine virus crossing the placenta and causing **Congenital Rubella Syndrome (CRS)** or fetal infection. Therefore, live vaccines like MMR (Measles, Mumps, Rubella), Varicella, and Yellow Fever are strictly contraindicated during pregnancy. Women are advised to avoid pregnancy for at least 4 weeks (28 days) after receiving the Rubella vaccine. **2. Analysis of Incorrect Options:** * **TT (Tetanus Toxoid):** This is a **toxoid vaccine** and is the most commonly administered vaccine in pregnancy to prevent maternal and neonatal tetanus. It is safe and mandatory. * **Polio:** While the live Oral Polio Vaccine (OPV) is generally avoided, the **Inactivated Polio Vaccine (IPV)** is a killed vaccine and can be administered if the risk of exposure is high (e.g., travel to endemic areas). * **Typhoid:** The **injectable Typhoid vaccine (Vi antigen)** is a subunit (inactivated) vaccine and can be given if there is a significant risk of infection. Only the oral Ty21a (live) vaccine is contraindicated. **3. NEET-PG High-Yield Pearls:** * **Rule of Thumb:** Live vaccines = Contraindicated; Inactivated/Toxoids = Generally safe. * **Exception:** The only live vaccine that can be given during pregnancy under high-risk exposure is **Yellow Fever** (if travel to an endemic zone is unavoidable). * **Postpartum:** The immediate postpartum period is the best time to vaccinate a non-immune woman with the MMR vaccine. * **Influenza:** The inactivated injectable flu vaccine is highly recommended for all pregnant women during any trimester.

Q: What is the procedure of choice in a woman with 12 weeks pregnancy and an atypical Pap smear?

Colposcopy. **Explanation:** The management of an abnormal Pap smear in pregnancy follows a conservative approach to prioritize the safety of the fetus while excluding invasive malignancy. **1. Why Colposcopy is the Correct Choice:** In any pregnant patient with an abnormal Pap smear (ASC-US with high-risk HPV, LSIL, HSIL, or ASC-H), the primary goal is to **rule out invasive cervical cancer**. Colposcopy is the gold standard for evaluation. In pregnancy, colposcopy is safe and highly accurate because the transformation zone is usually more visible due to physiological eversion (ectropion). The goal is to identify suspicious areas; biopsies are only performed if invasion is suspected. **2. Why Other Options are Incorrect:** * **Cone Biopsy (A):** This is contraindicated in pregnancy unless there is a strong suspicion of invasive cancer that cannot be confirmed by simple biopsy. It carries a high risk of hemorrhage, miscarriage, and preterm labor. * **MTP with Cone Biopsy (B):** Pregnancy is not an indication for termination in the case of a pre-invasive lesion (CIN). Treatment is typically deferred until 6–8 weeks postpartum. * **Hysterectomy (C):** This is an overtreatment for an atypical Pap smear and would result in fetal loss. It is only considered in advanced, invasive stages where the mother’s life is at immediate risk. **Clinical Pearls for NEET-PG:** * **Biopsy in Pregnancy:** Perform only if colposcopy suggests **invasive disease**. Avoid endocervical curettage (ECC) as it carries a risk of membrane rupture. * **Follow-up:** If CIN II or III is found, the patient is monitored with repeat colposcopy and cytology every 12–24 weeks. Definitive treatment (LEEP/Conization) is deferred until the **postpartum period**. * **Mode of Delivery:** Vaginal delivery is generally safe unless there is clinical evidence of invasive cervical cancer.

Q: At which gestational age does the uterus reach the umbilical level?

24 weeks. **Explanation:** The height of the uterine fundus is a critical clinical marker used to assess fetal growth and gestational age during prenatal visits. **1. Why 24 weeks is correct:** By convention and clinical observation, the fundus of the uterus reaches the **level of the umbilicus at 24 weeks** of gestation. While some older textbooks previously cited 20–22 weeks, modern obstetric guidelines (including DC Dutta and Williams Obstetrics) standardize the umbilical level at 24 weeks for examination purposes. At this stage, the fundal height in centimeters (measured from the symphysis pubis) typically correlates 1:1 with the weeks of gestation. **2. Analysis of Incorrect Options:** * **16 weeks:** At this stage, the fundus is midway between the symphysis pubis and the umbilicus. * **20 weeks:** The fundus is generally 2 finger-breadths below the umbilicus. * **28 weeks:** The fundus is approximately 3 finger-breadths above the umbilicus (at the junction of the lower 2/3 and upper 1/3 of the distance between the umbilicus and the xiphisternum). **3. NEET-PG High-Yield Clinical Pearls:** * **12 weeks:** The uterus first becomes an abdominal organ (just palpable at the pubic symphysis). * **36 weeks:** The fundus reaches the highest point (xiphisternum). * **40 weeks:** The fundal height actually *drops* to the level of 32 weeks due to "lightening" (engagement of the fetal head), though the flanks will be full. * **Rule of Thumb:** If the fundal height is significantly greater than the dates, consider multiple pregnancy, polyhydramnios, or molar pregnancy. If less than dates, consider IUGR or oligohydramnios.

Q: Pawlik's grip is done in obstetrics for assessment of?

Presenting part. **Explanation:** **Pawlik’s Grip**, also known as the **Third Leopold Maneuver**, is a clinical examination technique used to identify the **presenting part** and its mobility. 1. **Why it is correct:** The examiner uses one hand (usually the right) to grasp the lower pole of the uterus just above the symphysis pubis between the thumb and fingers. This maneuver confirms the findings of the first maneuver (Fundal grip) regarding the fetal pole. It helps determine if the presenting part is the head (hard, globular, ballotable) or breech (soft, irregular) and assesses whether the head is **engaged** or still mobile. 2. **Why other options are incorrect:** * **Gestational Age:** This is primarily assessed via the **Symphysio-fundal height (SFH)** or the first Leopold maneuver (Fundal grip) to estimate the height of the fundus relative to maternal landmarks. * **Fetal Maturity:** This refers to functional development (e.g., lung maturity) and is assessed via ultrasound parameters or amniocentesis, not by abdominal palpation. * **Labour:** While Pawlik’s grip can show if the head is engaged (a prerequisite for labor), labor itself is diagnosed by regular uterine contractions and progressive cervical changes. **High-Yield Clinical Pearls for NEET-PG:** * **Leopold Maneuvers Summary:** * **1st (Fundal Grip):** Identifies which fetal pole occupies the fundus. * **2nd (Lateral/Umbilical Grip):** Identifies the fetal back and limbs. * **3rd (Pawlik’s Grip):** Identifies the presenting part and its engagement (single-handed). * **4th (Pelvic Grip):** Confirms engagement and determines the **attitude** of the head (requires the examiner to face the patient's feet). * **Key Distinction:** Pawlik’s grip is the only maneuver performed with a **single hand**.

Q: In a pregnant patient with an elevated maternal serum alpha-fetoprotein (MSAFP), what is the recommended next step?

Perform an ultrasound (USG). **Explanation:** The management of an elevated Maternal Serum Alpha-Fetoprotein (MSAFP) follows a specific diagnostic algorithm. MSAFP is a screening tool, not a diagnostic one, and is most commonly elevated due to **incorrect dating** rather than fetal pathology. **1. Why Ultrasound (USG) is the correct next step:** The primary goal after an elevated MSAFP is to rule out physiological or benign causes. An ultrasound is performed to: * **Confirm Gestational Age:** MSAFP levels rise with pregnancy duration; if the pregnancy is further along than calculated by LMP, the level will appear falsely elevated. * **Identify Multiple Gestations:** Twins or triplets produce more AFP. * **Detect Fetal Demise:** AFP increases significantly following fetal death. * **Identify Structural Defects:** High-resolution USG can directly visualize Neural Tube Defects (NTDs), abdominal wall defects (omphalocele/gastroschisis), or renal anomalies. **2. Why other options are incorrect:** * **Option A:** Repeating the test is not recommended as it delays diagnosis and the window for screening (15–20 weeks) is narrow. * **Option C:** Amniocentesis (to check amniotic fluid AFP and Acetylcholinesterase) is an invasive procedure reserved for cases where USG is inconclusive or structural anomalies are suspected but not clearly visualized. * **Option D:** Termination is never the immediate step based on a screening test; a definitive diagnosis via USG or invasive testing is mandatory first. **NEET-PG High-Yield Pearls:** * **Ideal timing for MSAFP:** 16–18 weeks (Window: 15–20 weeks). * **Causes of Elevated MSAFP:** NTDs (Anencephaly, Spina Bifida), Omphalocele, Gastroschisis, Multiple pregnancy, and Renal anomalies (Finnish-type nephrosis). * **Causes of Low MSAFP:** Down Syndrome (Trisomy 21), Trisomy 18, Gestational Trophoblastic Disease, and Maternal Obesity. * **Most common cause of abnormal MSAFP:** Incorrect dating.

Question 1

Which of the following is not an indication for amniocentesis for chromosomal detection?

Accepted Answer

Gestational diabetes mellitus

Answer

Previous Down's syndrome child

Answer

Maternal age greater than 35 years

Answer

Parents with a known chromosomal anomaly

Question 2

Which of the following is NOT a finding associated with the prenatal diagnosis for Down syndrome?

Accepted Answer

Increased umbilical blood flow

Answer

Reduced femur and humerus length

Answer

Nuchal translucency greater than 3mm

Answer

Ventricular septal defect may be present

Question 3

What are the advantages of ultrasound nuchal translucency screening over biochemical screening for Down syndrome?

Accepted Answer

Offers better performance in multiple gestations.

Answer

Utilizes a transvaginal approach.

Answer

Provides more consistent measurements compared to laboratory tests.

Answer

Covers a wider gestational age range.

Question 4

Which vaccine is not indicated during pregnancy?

Accepted Answer

Rubella

Answer

Polio

Answer

Typhoid

Answer

TT

Question 5

What is the procedure of choice in a woman with 12 weeks pregnancy and an atypical Pap smear?

Accepted Answer

Colposcopy

Answer

Cone biopsy

Answer

MTP with cone biopsy

Answer

Hysterectomy

Question 6

At which gestational age does the uterus reach the umbilical level?

Accepted Answer

24 weeks

Answer

16 weeks

Answer

20 weeks

Answer

28 weeks

Question 7

Which of the following statements is incorrect regarding the management of iron deficiency anemia in pregnancy?

Accepted Answer

Oral iron therapy is not recommended if anemia is detected after 20 weeks of pregnancy.

Answer

Parenteral iron therapy typically leads to a significant increase in reticulocyte count within 7-14 days.

Answer

Parenteral iron therapy is considered ideal during the period of 30-36 weeks of gestation.

Answer

Blood transfusion may be indicated for severe anemia in patients beyond 36 weeks of gestation.

Question 8

Pawlik's grip is done in obstetrics for assessment of?

Accepted Answer

Presenting part

Answer

Gestational age

Answer

Fetal maturity

Answer

Labour

Question 9

An obese, 25-year-old G1P0 presents at 8 weeks gestational age for her first prenatal visit. She is concerned about her weight and wants advice on a diet and exercise regimen for a healthy pregnancy. What should NOT be advised to the patient during the counseling session?

Accepted Answer

She should gain at least 25 lb during the pregnancy because nutritional deprivation can result in impaired fetal brain development and intrauterine fetal growth retardation.

Answer

Marked obesity in pregnancy increases the risk of developing diabetes, hypertension, and fetal macrosomia.

Answer

Obese women will still have adequate fetal growth in the absence of any weight gain during pregnancy.

Answer

She should avoid initiating a vigorous exercise program to get in shape.

Question 10

In a pregnant patient with an elevated maternal serum alpha-fetoprotein (MSAFP), what is the recommended next step?

Accepted Answer

Perform an ultrasound (USG)

Answer

Repeat MSAFP measurement at a later date

Answer

Perform amniocentesis

Answer

Consider termination of pregnancy

Prenatal Care — MCQs

Prenatal Care — MCQs

On this page

Practice by Chapter

Want unlimited practice?